Karuna Therapeutics, Inc.
KRTX · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $186 | $248 | $207 | $53 |
| Short-Term Investments | $1,077 | $876 | $287 | $269 |
| Receivables | $5 | $0 | $2 | $0 |
| Inventory | $33 | $0 | $0 | $0 |
| Other Curr. Assets | $15 | $2 | $1 | $1 |
| Total Curr. Assets | $1,315 | $1,155 | $517 | $345 |
| Property Plant & Equip (Net) | $21 | $8 | $10 | $3 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $1 | $2 | $1 |
| Other NC Assets | $0 | $1 | $1 | $0 |
| Total NC Assets | $21 | $9 | $10 | $3 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,336 | $1,163 | $528 | $348 |
| Liabilities | – | – | – | – |
| Payables | $7 | $2 | $2 | $1 |
| Short-Term Debt | $3 | $2 | $2 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $42 | $0 | $0 | $0 |
| Other Curr. Liab. | $17 | $29 | $16 | $5 |
| Total Curr. Liab. | $68 | $34 | $20 | $7 |
| LT Debt | $14 | $3 | $5 | $2 |
| Deferred Rev, NC | $0 | -$1 | -$2 | $0 |
| Deferred Tax Liab, NC | $0 | $1 | $2 | $1 |
| Other NC Liab. | $0 | $0 | $0 | -$1 |
| Total NC Liab. | $14 | $3 | $5 | $2 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $82 | $37 | $26 | $9 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$998 | -$564 | -$288 | -$144 |
| AOCI | $0 | -$3 | -$0 | $0 |
| Other Equity | $2,252 | $1,694 | $790 | $483 |
| Total Equity | $1,254 | $1,126 | $502 | $339 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,336 | $1,163 | $528 | $348 |
| Net Debt | -$169 | -$243 | -$199 | -$50 |